Identification of Seronegative Women in Reproductive Age Group Eligible for Immunization Against Rubella
Objective: To emphasize the importance of vaccination against rubella in reproductive age group by introducing MMR vaccination in EPI programme.
Study design: Descriptive study. Place and Duration: Medicare Hospital Saidpur road Rawalpindi, 1st January 2016 to 30th June 2016.
Methodology: This study was conducted on 690 women of reproductive age group (15 to 40years) presented to Medicare hospital in outpatient departments and screening was done quantitatively using enzyme-linked immune assay (ELISA).
Results: Out of 696 women 576 (82.76%) were seropositive 73 (10.49%) were seronegative and 47 (6.75%) were equivocal.
Conclusion: Rubella vaccine is cost-effective but requires strengthening and modification of routine local immunization services and surveillance systems. We recommend selective rubella vaccination in childbearing age and postpartum vaccination of susceptible women should also be ensured along with routine MMR in childhood EPI programme.
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.